Urinary tract infections (UTIs) are among the most common infections, affecting millions of individuals around the globe. Antibiotic and non-antibiotic treatments like Canephron offer effective relief, but a new generation of research is showing huge promise for the use of certain probiotics in the management of UTIs.
UTIs are a common and frustrating infection, causing discomfort and inconvenience. Statistics show that over 150 million UTIs are diagnosed around the world each year. While anyone regardless of age or gender can contract a UTI, women account for the majority of cases. In fact, it is estimated that 50% - 60% of women will experience at least one UTI in their lifetime. For around 26% of these individuals, UTIs are considered recurrent.
UTIs are considered recurrent if they come back at least once within 6 months of the initial infection or 3 times within a year. Recent research has also suggested a link with age, particularly in females. Findings showed that 53% of women who were 55 or older reported recurrence within 1 year, compared to 36% of younger women.
While antibiotics are extremely effective in resolving bacterial infections like UTIs, overuse of these medications can have negative effects. Given the dangers of overuse and side effects, non-antibiotic solutions like Canephron, which is clinically proven to treat the cause and symptoms of uncomplicated UTIs and prevent recurrence, are important. But what if there was a way to further support your urinary health?
Recently, researchers have investigated the use of certain strains of probiotics for the treatment and prevention of uncomplicated UTIs and recurrent infections in women. The results of these investigations have been positive, especially for those containing Lactobacilli bacteria. This is also the dominant beneficial bacteria found in the vagina, usually responsible for keeping the growth of other bacteria and yeast regulated, essentially preventing infections. In these studies, Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 were found to be particularly effective strains.
But not all probiotics are created equal. Reuterina Femme is a purpose-made probiotic designed to maintain and restore healthy flora in the vagina. Containing both Lactobacillus rhamnosus GR-1 and L. reuteri RC-14, Reuterina Femme helps to restore and replenish vaginal flora, helping keep infections like UTIs at bay.
Probiotics for UTIs can be effective on their own, but when combined with other medications, they can form part of the ultimate UTI prevention strategy. For example, when it comes to long-term prevention of recurrent UTIs, non-antibiotic medications like Canephron make the ideal partner to Reuterina Femme.
In addition to addressing the cause and symptoms of UTIs, Canephron’s unique 4-in-1 action is clinically proven to prevent recurrent UTIs. Its antibacterial properties can work alongside the efforts of the good bacteria found in Reuterina Femme, preventing the growth of E. coli bacteria in the urinary tract and stopping dormant infections from returning, creating the ultimate defence against recurrent UTIs.
UTIs are a painful and inconvenient experience that millions of women go through each year. Although most UTIs are not considered dangerous, these often persistent infections can have a marked impact on quality of life. For those women who experience recurrent infections, probiotics for UTIs like Reuterina Femme, combined with non-antibiotic medications like Canephron, can offer a safe and effective solution to maintaining urinary health.
Both medications are available over the counter at all leading pharmacies, including Clicks and Dis-Chem. Together, Reuterina Femme and Canephron are the ultimate UTI-fighting combination, helping you take charge of your urinary health and avoid pesky UTIs.
